Work

Abstract P3-06-26: Measurement of domain-specific HER2 (ERBB2) expression classifies benefit from Trastuzumab in breast cancer

Year: 2015

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs14-p3-06-26

Authors: Daniel E Carvajal-Hausdorf, Kurt A Schalper, Lajos Pusztai, Amanda Psyrri, Konstantine T Kalogeras, Vassiliki Kotoula, George Fountzilas, David L Rimm

Institutions: Yale University, University General Hospital Attikon, Hellenic Cooperative Oncology Group, Aristotle University of Thessaloniki

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1656880393

Cites:

Cited by:

Related to: 10